Clinical characteristics of moderate or severe COVID‐19 infection in patients with rheumatic diseases and analysis of risk factors leading to severe disease
W Wang, X Sun, R Fan, L Xu… - International Journal of …, 2023 - Wiley Online Library
Objective To explore the clinical characteristics of rheumatic disease (RD) patients who
suffered from moderate or severe coronavirus disease 2019 (COVID‐19) infection and to …
suffered from moderate or severe coronavirus disease 2019 (COVID‐19) infection and to …
Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort
S Panchawagh, D Bohdana, M Kuwana… - Rheumatology …, 2023 - Springer
Data on short-term safety of COVID-19 vaccination in patients with systemic sclerosis (SSc)
were explored previously in the first COVID-19 vaccination in autoimmune diseases …
were explored previously in the first COVID-19 vaccination in autoimmune diseases …
Knowledge mapping of COVID-19 and autoimmune diseases: a visual and bibliometric analysis
Y Zhang, Z Jia, X Xia, J Wang - Clinical and Experimental Medicine, 2023 - Springer
Background Many studies have shown an association between COVID-19 and autoimmune
diseases (ADs). Studies on COVID-19 and ADs have also increased significantly, but there …
diseases (ADs). Studies on COVID-19 and ADs have also increased significantly, but there …
Recommendations for enhanced primary series (third dose) COVID-19 vaccination for people with rheumatic diseases: Chapter of Rheumatologists, College of …
Methods: Literature reviews were performed regarding the necessity, efficacy, safety and
strategies for enhanced primary series COVID-19 vaccination in PRDs. Recommendations …
strategies for enhanced primary series COVID-19 vaccination in PRDs. Recommendations …
Approach to vaccination in systemic lupus erythematosus on biological treatment
R Yıldırım, T Oliveira, DA Isenberg - Annals of the Rheumatic Diseases, 2023 - ard.bmj.com
In recent years, treat-to-target strategy and early intervention strategies with
immunosuppressive agents have attempted to improve the prognosis and outcome in …
immunosuppressive agents have attempted to improve the prognosis and outcome in …
Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'
H Yang, J Xu, L Shi, G Duan, Y Wang - Annals of the Rheumatic …, 2023 - ard.bmj.com
With great interest, we have read the recent article entitled 'Prevalence and clinical
outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and …
outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and …
The kinetics of humoral and cellular responses after the booster dose of COVID-19 vaccine in inflammatory arthritis patients
J Wroński, B Jaszczyk, L Roszkowski, A Felis-Giemza… - Viruses, 2023 - mdpi.com
Impaired immunogenicity of COVID-19 vaccinations in inflammatory arthritis (IA) patients
results in diminished immunity. However, optimal booster vaccination regimens are still …
results in diminished immunity. However, optimal booster vaccination regimens are still …
Prevalence and factors associated with flares following COVID-19 mRNA vaccination in patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: a …
Objective To determine prevalence and factors associated with flares post Coronavirus
disease 2019 (COVID-19) mRNA vaccination in patients with rheumatoid arthritis (RA) …
disease 2019 (COVID-19) mRNA vaccination in patients with rheumatoid arthritis (RA) …
Humoral and cellular immunity in patients with rare autoimmune rheumatic diseases following SARS-CoV-2 vaccination
Objectives Coronavirus 2019 vaccine responses in rare autoimmune rheumatic diseases
(RAIRDs) remain poorly understood; in particular there is little known about whether people …
(RAIRDs) remain poorly understood; in particular there is little known about whether people …
Factors associated with poor outcomes in SLE patients with COVID-19: Data from ReumaCoV-Brazil register
JS Carvalho, ET dos Reis Neto, AM Kakehasi… - Lupus, 2023 - journals.sagepub.com
Objectives To evaluate factors associated with COVID-19 severity outcomes in patients with
systemic lupus erythematosus (SLE). Methods This was a cross-sectional analysis of …
systemic lupus erythematosus (SLE). Methods This was a cross-sectional analysis of …